Outpatient Oncology Aromatherapy for Symptom Management

NCT04449315 | Completed

• 1 other identifier: CentralDuPage
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this research study is to determine whether using aromatherapy during chemotherapy infusion treatments in the outpatient Oncology setting promote relief of nausea and anxiety. The objectives of this study are: 1. To promote relief of nausea using peppermint aromatherapy oil in an outpatient oncology setting. 2. To promote relief of anxiety using lavender aromatherapy oil in an outpatient oncology setting.

Conditions

Anxiety; Nausea

Outcome Measures

Primary Outcomes (1)

• Post Intervention Interview From

  After the patients' infusion they will be asked questions from this form

  Immediately upon Completion of the patient's infusion

Study Arms (1)

Peppermint and Lavender Essential Oil

EXPERIMENTAL

Young Living Essential oil of Peppermint and Lavender will be used to patients who meet the inclusion criteria.

Other: Young Living Lavender Essential Oil

Interventions

Young Living Lavender Essential Oil OTHER

For qualified patients one to two drops of hospital approved essential oil will be placed on a 4X4 gauze and will be offered to the patient during their infusion visit. This gauze will be placed in a sealable clear plastic bag and the patient will be instructed to use one sniff at a time.

Also known as: Young Living Peppermint Essential Oil

Peppermint and Lavender Essential Oil

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• All outpatient Oncology patients \> 18 years of age
• Non pregnant
• Not cognitively impaired
• English speaking only
• Patients who report nausea and/or anxiety

You may not qualify if:

• All outpatient oncology patients \<18 years of age
• Pregnant
• Cognitively impaired
• Non-English Speaking
• Patients who do not report nausea and/or anxiety
• Patients with a known allergy to peppermint and/or lavender aromatherapy oil

Sponsors & Collaborators

• Central DuPage Hospital: lead

Study Sites (1)

Central DuPage

Winfield, Illinois, 60190, United States

Location

MeSH Terms

Conditions

Anxiety Disorders; Nausea

Condition Hierarchy (Ancestors)

Mental Disorders; Signs and Symptoms, Digestive; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Lorraine Mack, MSN

  Central DuPage Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 12, 2020
• First Posted: June 26, 2020
• Study Start: October 10, 2020
• Primary Completion: May 31, 2022
• Study Completion: May 31, 2022
• Last Updated: April 15, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)